Trials / Withdrawn
WithdrawnNCT02291978
MR Guided High Intensity Focused Ultrasound for Lumbar Back Pain
A Feasibility Study to Evaluate the Safety and Initial Effectiveness of MR Guided High Intensity Focused Ultrasound (MRgHIFU) in the Treatment of Facetogenic Lumbar Back Pain
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The primary purpose of this protocol is to assess the ExAblate 2100 MR guided high intensity focused ultrasound device as an intervention for treatment of facetogenic lower back pain.
Detailed description
This is a single group, single arm, open/nonblinded, non-randomized study. The primary outcomes are safety and preliminary efficacy. The InSightec ExAblate 2100 MRgHIFU system is a non-invasive thermal ablation device fully integrated with an MR imaging system and used for the ablation of soft tissue and bone.The study will reach primary completion 12 months from the time the study opens to accrual.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ExAblate 2100 | The InSightec ExAblate 2100 MRgHIFU system is a non-invasive thermal ablation device fully integrated with an MR imaging system and used for the ablation of soft tissue and bone. |
Timeline
- Start date
- 2014-10-01
- Primary completion
- 2020-02-20
- Completion
- 2020-02-20
- First posted
- 2014-11-17
- Last updated
- 2020-02-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02291978. Inclusion in this directory is not an endorsement.